7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,106.90

-1,274.91

-1.63%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

ASX - Delayed Quote AUD

Aroa Biosurgery Limited (ARX.AX)

0.5500 +0.0150 (+2.80%)

At close: October 30 at 4:10:12 PM GMT+11

Inside Biotech: Aroa Biosurgery’s Symphony improves diabetic foot ulcer healing in US clinical trial

Proactive 26d ago

ARX.AX
+2.80%
AROAF
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

PR Newswire 1mo ago

ARX.AX
+2.80%
ARX
ASX Penny Stocks Spotlight Aroa Biosurgery And Two More Top Picks

Simply Wall St. 5mo ago

ARX.AX
+2.80%
SRG.AX

DUR.AX
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™

PR Newswire 10d ago

ARX.AX
+2.80%
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

PR Newswire 26d ago

ARX.AX
+2.80%
ASX Penny Stocks To Watch In April 2026

Simply Wall St. 6mo ago

LBL.AX

OBM.AX

EDU.AX
Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.

PR Newswire 3mo ago

ARX.AX
+2.80%
Exploring 3 High Growth Tech Stocks in Australia

Simply Wall St. 8mo ago

CGS.AX

PME.AX

KYP.AX
While institutions own 32% of Aroa Biosurgery Limited (ASX:ARX), individual investors are its largest shareholders with 42% ownership

Simply Wall St. 11mo ago

ARX.AX
+2.80%
AROAF

Mobilize your Website

View Site in Mobile | Classic

Share by: